Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pinduoduo, CV Sciences, and Ampio and Encourages Investors to Contact the Firm
October 21, 2018 18:00 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 21, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Pinduoduo Inc., CV Sciences,...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against LogMeIn, Pinduoduo, Nevro, and CV Sciences and Encourages Investors to Contact the Firm
October 16, 2018 19:52 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 16, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of LogMeIn, Inc., Pinduoduo...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CV Sciences, Lannett, and Ampio and Encourages Investors to Contact the Firm
October 10, 2018 19:19 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of CV Sciences, Inc., Lannett...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Nevro, CV Sciences, and Lannett and Encourages Investors to Contact the Firm
October 03, 2018 18:56 ET
|
Bragar Eagel & Squire
NEW YORK, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Nevro Corp., CV Sciences,...
Streetwise Reports Examines a Cannabis Company that Has Better Numbers than Tilray at 1/25th the Price
September 25, 2018 13:17 ET
|
Streetwise Reports Llc
SAN FRANCISCO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Tilray's wild fluctuations have grabbed the headlines the past few days, but Fincom Investment Partners profiles a rapidly emerging player in the...
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CV Sciences, Papa John’s, and Qurate and Encourages Investors to Contact the Firm
September 18, 2018 20:07 ET
|
Bragar Eagel & Squire
NEW YORK, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of CV Sciences, Inc., Papa...
CV Sciences, Inc. Achieves Industry’s First Hemp Extract GRAS Self-Affirmation
September 10, 2018 19:33 ET
|
CV Sciences, Inc.
First Hemp Extract to Achieve Highly Sought-After Self-Affirmed GRAS Status Designation LAS VEGAS, Sept. 10, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”,...
CV Sciences, Inc. provides corporate update to shareholders
August 30, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Aug. 30, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our” or “we”) would like to assure our shareholders that we are keenly aware of recent...
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against CV Sciences, Inc. (CVSI) and Encourages Investors to Contact the Firm
August 29, 2018 19:10 ET
|
Bragar Eagel & Squire
NEW YORK, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the District of Nevada on behalf of...
CV Sciences, Inc. Responds to Class Action Lawsuit
August 28, 2018 08:45 ET
|
CV Sciences, Inc.
LAS VEGAS, Aug. 28, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”) has been informed of a class action lawsuit filed against the Company...